Uniprot ID: | |
Secondary ID: | |
Symbol: | miR-122 |
Other Name: | |
Class: | Epigenetics |
Type: | anti-fibrotic |
Molecular Function: |
Category I | Category II | Category III |
---|---|---|
Intracellular | Epigenetics | microRNA |
Reference Record 1
PubMed ID | 28544786 | Compound ID | |
CAS | Name | ||
Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | HSC proliferation | ||
Process III | prevenet collagen deposition | ||
Mechanism |
Reference Record 2
PubMed ID | 25909171 | Compound ID | |
CAS | Name | ||
Model | vitro,human,mice | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | |||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting TGF-β-miR-122-FN1/SRF signaling |
Reference Record 3
PubMed ID | 25040043 | Compound ID | |
CAS | Name | ||
Model | mice | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism | Targeting HIF-1α, vimentin and MAP3K3 |
Reference Record 4
PubMed ID | 23178710 | Compound ID | |
CAS | Name | ||
Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | HSCs activation,HSCs proliferation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting P4HA1 |
Reference Record 5
PubMed ID | 22820290 | Compound ID | |
CAS | Name | ||
Model | human | Fibrosis Disease | Liver fibrosis |
Process I | attenue inflammation | ||
Process II | EMT | ||
Process III | |||
Mechanism |